scholarly journals The Efficacy of Therapeutic Angiogenesis Using Basic Fibroblast Growth Factor in Patients With Coronary Artery Disease: A Double-Blind, Placebo-Controlled Study

2016 ◽  
Vol 5 (1) ◽  
pp. 22-28
Author(s):  
Hossein Ahmadi ◽  
Armita Mahdavi ◽  
Morteza Daliri ◽  
Mohammad Imani ◽  
Abbasali Karimi ◽  
...  
Keyword(s):  
Coronary Artery Disease ◽  
Coronary Artery ◽  
Growth Factor ◽  
Fibroblast Growth Factor ◽  
Therapeutic Angiogenesis ◽  
Controlled Study ◽  
Fibroblast Growth ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Artery Disease

scholarly journals Pharmacological Treatment of Coronary Artery Disease With Recombinant Fibroblast Growth Factor-2

Circulation ◽  
2002 ◽  
Vol 105 (7) ◽  
pp. 788-793 ◽  
Author(s):  
Michael Simons ◽  
Brian H. Annex ◽  
Roger J. Laham ◽  
Neal Kleiman ◽  
Timothy Henry ◽  
...  
Keyword(s):  
Coronary Artery Disease ◽  
Coronary Artery ◽  
Growth Factor ◽  
Fibroblast Growth Factor ◽  
Pharmacological Treatment ◽  
Fibroblast Growth Factor 2 ◽  
Fibroblast Growth ◽  
Artery Disease

Acute and chronic effects of flavanol-rich cocoa on vascular function in subjects with coronary artery disease: a randomized double-blind placebo-controlled study

2006 ◽  
Vol 111 (1) ◽  
pp. 71-80 ◽  
Author(s):  
H. M. Omar Farouque ◽  
Michael Leung ◽  
Sarah A. Hope ◽  
Mauro Baldi ◽  
Clyde Schechter ◽  
...  
Keyword(s):  
Coronary Artery Disease ◽  
Coronary Artery ◽  
Vascular Function ◽  
Cellular Adhesion ◽  
Controlled Study ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Cellular Adhesion Molecules ◽  
Artery Disease ◽  
Daily Total

Evidence suggests that flavonoid-containing diets reduce cardiovascular risk, but the mechanisms responsible are unclear. In the present study, we sought to determine the effect of flavanol-rich cocoa on vascular function in individuals with CAD (coronary artery disease). Forty subjects (61±8 years; 30 male) with CAD were recruited to a 6-week randomized double-blind placebo-controlled study. Subjects consumed either a flavanol-rich chocolate bar and cocoa beverage daily (total flavanols, 444 mg/day) or matching isocaloric placebos daily (total flavanols, 19.6 mg/day) for 6 weeks. Brachial artery FMD (flow-mediated dilation) and SAC (systemic arterial compliance) were assessed at baseline, 90 min following the first beverage and after 3 and 6 weeks of daily consumption. Soluble cellular adhesion molecules and FBF (forearm blood flow) responses to ACh (acetylcholine chloride; 3–30 μg/min) and SNP (sodium nitroprusside; 0.3–3 μg/min) infusions, forearm ischaemia and isotonic forearm exercise were assessed at baseline and after 6 weeks. FMD, SAC and FBF responses did not differ between groups at baseline. No acute or chronic changes in FMD or SAC were seen in either group. No difference in soluble cellular adhesion molecules, FBF responses to ischaemia, exercise, SNP or ACh was seen in the group receiving flavanol-rich cocoa between baseline and 6 weeks. These data suggest that over a 6-week period, flavanolrich cocoa does not modify vascular function in patients with established CAD.

Sign in / Sign up

Export Citation Format

Share Document